These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34874654)

  • 1. [The result of prospective randomized study CITADEL - the efficacy and safety of drug cytoflavin in postcovid rehabilitation].
    Putilina MV; Teplova NV; Bairova KI; Petrikeeva AE; Shabalina NI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):45-51. PubMed ID: 34874654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
    Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
    Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effectiveness of cytoflavin in complex therapy of patients with the coronavirus infection COVID-19].
    Ekusheva EV; Voitenkov VB; Rizakhanova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):33-39. PubMed ID: 35041310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome].
    Esipov AV; Ivolgin AF; Khritinin DF; Katenko SV; Kazakov SP; Karakozov AG; Kalyagin IE; Levchenko OB; Molodova AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):46-51. PubMed ID: 31626218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury].
    Skoromets AA; Pugacheva EL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].
    Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder].
    Polunina AG; Osinovskaia NA; Gudkova AN; Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):28-33. PubMed ID: 24662341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease].
    Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV
    Ter Arkh; 2016; 88(5):55-61. PubMed ID: 27239928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
    Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
    Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modern methods of energy homeostasis correction in elderly patients].
    Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
    Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of cytoflavin in the acute period of hemorrhagic stroke].
    Sazonov IE; Klementenko TD; Kudinov AA; Avramenko MA; Yarmonov SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(2):23-26. PubMed ID: 29560936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytoflavin in the complex therapy of multiple sclerosis].
    Karpov SM; Shevchenko PP; Nazarova EO; Vyshlova IA; Dolgova IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):37-39. PubMed ID: 30499494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke].
    Shestakov VV; Kosenkova NV; Kichigina EV; Larikova TN; Starikova NL
    Klin Med (Mosk); 2011; 89(1):38-40. PubMed ID: 21516764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic aspects of the use of cytoflavine in the treatment of сhronic post-traumatic headache].
    Iskra DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):41-44. PubMed ID: 28091500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antioxidant therapy on neurotrophins and processes of rehabilitation after stroke].
    Karakulova YV; Selyanina NV; Zhelnin AV; Filimonova TA; Cepilov SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):36-39. PubMed ID: 27635609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].
    Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke].
    Sazonov IE; Kudinov AA; Fedotova EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the effects of cytoflavin on symptoms of depression and autonomic dysfunction in patients with organic depressive disorder].
    Gudkova AN; Osinovskaia NA; Polunina AG; Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):50-5. PubMed ID: 24430035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytoflavin in patients with vertigo and dizziness in a distant period of mild traumatic brain injury].
    Lavrick SY; Borisov AS; Shprakh VV; Mikhalevich IM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(4):46-50. PubMed ID: 32490618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction].
    Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV
    Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.